Innoviva, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burlingame, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Innoviva, Inc. has filed 1,666 SEC EDGAR filings since 21 Mar 2000

SEC filing history

Showing 751-775 of 1,000 matching filings.

Per page
25
Current page
31
4

FORM 4 -

Filing date
28 Jul 2014
Reporting date
24 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE 8-K

Filing date
16 Jul 2014
Reporting date
16 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
16 Jul 2014
Reporting date
16 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
10 Jul 2014
Reporting date
01 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

COVER SHEET

Filing date
09 Jul 2014
Reporting date
09 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
07 Jul 2014
Reporting date
07 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
02 Jul 2014
Reporting date
02 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
30 Jun 2014
Reporting date
30 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date
30 Jun 2014
Reporting date
30 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
23 Jun 2014
Reporting date
19 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 Jun 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 Jun 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 Jun 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 Jun 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 Jun 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 Jun 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

8-K

Filing date
17 Jun 2014
Reporting date
16 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A -

Filing date
12 Jun 2014
Reporting date
02 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A -

Filing date
12 Jun 2014
Reporting date
02 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A -

Filing date
12 Jun 2014
Reporting date
02 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A -

Filing date
12 Jun 2014
Reporting date
02 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A -

Filing date
12 Jun 2014
Reporting date
02 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A -

Filing date
12 Jun 2014
Reporting date
02 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
12 Jun 2014
Reporting date
02 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30319

THERAVANCE, INC. 8K

Filing date
11 Jun 2014
Reporting date
11 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .